Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Diabetes|September 11, 2014
Preserved β-cell function in type 1 diabetes by mesenchymal stromal cellsPer-Ola Carlsson, Erik Schwarcz, Olle Korsgren, et al.
Nutrients|August 26, 2022
Diet-Treated Gestational Diabetes Mellitus Is an Underestimated Risk Factor for Adverse Pregnancy Outcomes: A Swedish Population-Based Cohort StudyInga Rós Valgeirsdóttir, Ulf Hanson, Erik Schwarcz, et al.
BMJ Open Diabetes Research & Care|November 9, 2022
Pregnancy induces pancreatic insulin secretion in women with long-standing type 1 diabetesDaniel Espes, Louise Magnusson, José Caballero-Corbalan, et al.
European Journal of Endocrinology|November 20, 2015
Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patientsPia Burman, Britt Edén-Engström, Bertil Ekman, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|March 28, 2023
Previous pre-eclampsia, gestational diabetes mellitus and the risk of cardiovascular disease: A nested case-control study in SwedenKarin Hildén, Anders Magnuson, Scott Montgomery, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 30, 2015
Randomized controlled study in pregnancy on treatment of marked hyperglycemia that is short of overt diabetesHelena E Fadl, Susanne Gärdefors, Ragnhild Hjertberg, et al.
Diabetes Care|November 17, 2020
Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDIMarcus Lind, Arndís F Ólafsdóttir, Irl B Hirsch, et al.
Diabetes Technology & Therapeutics|April 3, 2018
A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3)Arndís F Ólafsdóttir, William Polonsky, Jan Bolinder, et al.
Diabetes, Obesity & Metabolism|November 17, 2020
The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5)Arndís F Ólafsdóttir, Jan Bolinder, Tim Heise, et al.
Diabetes Care|July 10, 2020
The Association Between HbA1c and Time in Hypoglycemia During CGM and Self-Monitoring of Blood Glucose in People With Type 1 Diabetes and Multiple Daily Insulin Injections: A Randomized Clinical Trial (GOLD-4)Shilan Seyed Ahmadi, Klara Westman, Aldina Pivodic, et al.
Pageof 2